Tables
- Table 1—
Time-course of work-related symptoms and occupational diseases in apprentices exposed to laboratory animals
Years in the programme Incidence-density 1 2 3 4 Number present at visit 136 345 355 98 Skin reactivity Programme-related antigen 14 (10.3) 37 (10.7) 29 (8.2) 5 (5.1) 85/1075 (7.9) Mites 4 (2.9) 14 (4.1) 14 (3.9) 1 (1.0) 33/716 (4.6) Pets 9 (6.6) 7 (2.0) 14 (3.9) 5 (5.1) 35/926 (3.8) Pollens 0 (0) 8 (2.3) 8 (2.3) 1 (1.0) 17/788 (2.2) Work-related symptoms Skin 4 (2.9) 33 (9.6) 39 (11.0) 5 (5.1) 81/1051 (7.7) Rhinoconjunctivitis 17 (12.5) 48 (13.9) 30 (8.5) 4 (4.1) 99/961 (10.3) Respiratory 1 (0.7) 11 (3.2) 9 (2.5) 1 (1.0) 22/1115 (2.0) Occupational Rhinoconjunctivitis 9 (6.6) 24 (7.0) 29 (8.2) 0 (0) 62/1096 (5.7) Asthma 5 (3.7) 9 (2.6) 13 (3.7) 1 (1.0) 28/1043 (2.7) Data presented as n (%) or incidence (%)
Total number of participants=417 except for the assessment of occupational asthma (n=373) because 44 students refused the methacholine inhalation test
number of cases/person-yrs in the programme
- Table 2—
Incidence of work-related symptoms in relation to the time of occurrence of skin reactivity to laboratory animal-derived antigens
Skin reactivity PPV Present Absent Before symptoms Same time as symptoms After symptoms No symptoms Cutaneous symptoms 21 22 7 67 31 32/117 28 (19–35) Work-related RC symptoms Nasal 18 17 13 42 44 27/90 30 (21–41) Ocular 14 16 17 59 31 22/106 21 (14–30) Nasal and/or ocular 17 19 17 26 46 27/90 30 (21–41) Work-related respiratory symptoms Dyspnoea 7 1 5 110 8 8/123 6.5 (3–13) Wheezing 8 4 6 111 3 10/129 8.0 (4–14) Dyspnoea and/or wheezing 9 4 6 103 3 11/22 9.0 (5–16) Data are presented as n except for positive predictive values (PPV) which show incidence calculated as described below as % (95% confidence interval (CI))
The numerator is the total of (all incident cases of symptoms detected after the occurrence of skin reactivity)+(half of incident cases of symptoms detected at the same time as skin reactivity) (see text for rationale)
the denominator is the number of subjects with skin reactivity at baseline or at follow-up and without the pertinent symptom at baseline
CI values are computed under the naive assumption that PPV is a simple proportion